Close this search box.

Innovent hires Gracell vet Samuel Zhang as CBO

ARTICLE | Management Tracks

Plus: CEO changes at Lexicon, Avacta and Sphere Fluidics, and updates from Generate, Charm, ViaNautis and more

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst  

April 30, 2024 10:55 PM UTC

Innovent Biologics Inc. (HKEX:1801) hired Samuel Zhang as global CBO. Zhang was CBO of Gracell Biotechnologies Inc., where he played a role in that company’s acquisition by AstraZeneca plc (LSE:AZN; NASDAQ:AZN). Before Gracell, he was CBO at NeoImmuneTech Inc. (KOSDAQ:950220).

Lonnel Coats will retire as CEO and board member of Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) on July 7. The cardiovascular and metabolic disorders company has begun the search for a successor…